Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer.

Mol Oncol · 2019 · PMC6487710 · PMID 30672098

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Notably, the positive rate of ctDNA in M1 patients exceeded that of M0 patients (85.71% vs 57.81%, Table 2 ), although the discrepancy did not reach statistical significance, possibly due to the small number of M1 patients in our study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.